← Back to Search

Corticosteroid

Dexamethasone Oral for Bronchiolitis

Phase 4
Waitlist Available
Led By Allison E Williams, MD
Research Sponsored by Allison Williams
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up admission vitals through discharge paperwork printing time, average of 24-96 hours
Awards & highlights

Study Summary

This trial will test whether dexamethasone can improve outcomes for children hospitalized with non-RSV bronchiolitis, with the goal of reducing length of stay.

Eligible Conditions
  • Bronchiolitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~admission vitals through discharge paperwork printing time, average of 24-96 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and admission vitals through discharge paperwork printing time, average of 24-96 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hospital Length of Stay
Secondary outcome measures
7-day Same-Cause Revisit Rate
Severity of Bronchiolitis

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Dexamethasone ArmExperimental Treatment1 Intervention
Participants will be given dexamethasone (0.6mg/kg/dose) in a single oral dose in addition to the standard of care for bronchiolitis (supplemental oxygen, antipyretics, suctioning etc.)
Group II: Placebo ArmPlacebo Group1 Intervention
Participants will be given a placebo of sugar water (0.6ml/kg/dose) in a single oral dose and standard of care for bronchiolitis (supplemental oxygen, antipyretics, suctioning etc.)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dexamethasone Oral
2020
N/A
~14110

Find a Location

Who is running the clinical trial?

Allison WilliamsLead Sponsor
University of Pittsburgh Medical CenterOTHER
70 Previous Clinical Trials
76,247 Total Patients Enrolled
Allison E Williams, MDPrincipal InvestigatorUniversity of Pittsbrgh, UPMC Children's Hospital of Pittsburgh

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What other research has been conducted on the efficacy of Dexamethasone Oral?

"Currently, 553 clinical trials examining Dexamethasone Oral are in progress. Of those ongoing studies, 144 are currently in the third stage of development. Although the bulk of these experiments take place at one location in Mishawaka, Indiana, other trial sites across America total 18 618."

Answered by AI

Has the Food and Drug Administration authorized Dexamethasone Oral for therapeutic purposes?

"The safety of Dexamethasone Oral was rated 3 on our internal scale, as the treatment is already approved and in its fourth phase of trials."

Answered by AI

Does this experimental protocol accept participants aged 65 and up?

"The parameters of this clinical trial are set to include patients aged 1 Day to 2 years old. Out of the 600 participants, 98 will be under 18 and 501 over 65."

Answered by AI

What medical conditions may be addressed through the administration of Dexamethasone Oral?

"Dexamethasone Oral is a frequent medication prescribed to treat ophthalmia, sympathetic. It also has been successfully used to alleviate symptoms of eye disorders and macular edema connected with branch retinal vein occlusion."

Answered by AI

What is the current enrolment figure for this clinical trial?

"This clinical trial has now closed its recruitment period. Initially posted in February 2020 and most recently updated in April 2022, it no longer is accepting applications. However, those seeking trials related to bronchiolitis viral can find 39 studies actively enrolling participants while Dexamethasone Oral research presently has 553 active trails recruiting patients."

Answered by AI

Do I meet the criteria to participate in this research?

"This clinical trial is seeking up to 50 individuals with bronchiolitis of viral origin between 1 day and 2 years old. If your qualifications meet these criteria, you are eligible for participation in the study."

Answered by AI

Are there any slots left for participation in this trial?

"Recruitment for this clinical trial has been concluded. It was initially posted on February 3rd 2020 and the latest update was April 8th 2022. For interested persons, 39 trials are actively recruiting patients with bronchiolitis viral and 553 studies are currently enrolling participants to test Dexamethasone Oral's efficacy."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Steroid Use in Non-RSV Bronchiolitis
Allison Williams 2020. "Steroid Use in Non-RSV Bronchiolitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04221087.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top